Strata Critical Medical, Inc.SRTA

NasdaqHealthcareServices-Health Services
Price (close)
$5.27
Market cap
$454.3M
P/E
11.3x
Revenue (TTM)
$256.0M
Net income
$40.2M
Dividend yield
—
1-year total return
3.3%
Net margin
15.7%
Revenue growth
66.8%
Debt / equity
—

What Strata Critical Medical, Inc. does.

Strata Critical Medical, Inc.(f/k/a Blade Air Mobility, Inc.) (“Strata” or the “Company”) is a time-critical logistics and medical services provider to the United States healthcare industry. The Company operates one of the nation’s largest air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated “one call” solution for donor organ recovery. Strata’s core services include air and ground logistics, organ placement, surgical organ recovery, normothermic regional perfusion and preservation for the transplant industry, as well as perfusion staffing and equipment solutions for cardiovascular surgery centers, offered under the Trinity Medical Solutions (“Trinity”) and Keystone Perfusion Services LLC (“Keystone”) brands.

Strata’s mission is to increase the number of organs that are successfully transplanted while leveraging the Company’s expertise and resources to provide other medical and logistics services to a broader customer base. Strata’s goals are closely aligned with those of all participants in the transplant ecosystem, including transplant centers, regulators, Organ Procurement Organizations (“OPOs”) and other service providers. We believe that, by working with Strata, industry participants can save money, save more lives and operate more efficiently by working with Strata.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue——$146.1M$225.2M$146.8M$197.1M
Net income-$20.5M—-$27.3M-$56.1M-$27.3M$41.3M
Free cash flow——-$37.9M-$34.5M-$33.4M-$58.5M

More on SRTA.

Figures from Strata Critical Medical, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.